Literature DB >> 11923451

Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy.

Sophie Burlet1, Christopher J Tyler, Christopher S Leonard.   

Abstract

Compelling evidence links the recently discovered hypothalamic peptides Hypocretin/Orexin (Hcrt/Orx) to rapid eye movement sleep (REM) control and the sleep disorder narcolepsy, yet how they influence sleep-related systems is not well understood. We investigated the action of Hcrt/Orx on mesopontine cholinergic (MPCh) neurons of the laterodorsal tegmental nucleus (LDT), a target group whose function is altered in canine narcolepsy and appears pivotal for normal REM and wakefulness. Extracellular recordings from mouse brainstem slices revealed that Hcrt/Orx evoked prolonged firing of LDT neurons. Whole-cell recordings revealed that Hcrt/Orx had actions on both presynaptic neurons and at postsynaptic sites. Hcrt/Orx produced an increase in frequency and amplitude of spontaneous EPSCs without equivalent effect on IPSCs, by triggering action potentials and enhancing spike-evoked synaptic transmission in glutamatergic afferents. Postsynaptically, Hcrt/Orx produced an inward current and an increase in membrane current noise, which were accompanied by a conductance increase. These persisted in TTX, ionotropic glutamate receptor antagonists, and low extracellular calcium. Both presynaptic and postsynaptic actions were specific because they were not mimicked by an Hcrt/Orx fragment, and both actions were observed for cholinergic and noncholinergic LDT neurons. Finally, extracellular recordings during postsynaptic potential blockade demonstrated that postsynaptic actions of Hcrt/Orx alone could evoke prolonged firing. In the context of other recent work, our findings suggest that Hcrt/Orx neurons may coordinate the activity of the entire reticular activating system during waking. Moreover, these findings address specific hypotheses regarding the cellular mechanisms underlying REM disregulation in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923451      PMCID: PMC6758338          DOI: 20026234

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Characterization of the extent of pontomesencephalic cholinergic neurons' projections to the thalamus: comparison with projections to midbrain dopaminergic groups.

Authors:  S A Oakman; P L Faris; C Cozzari; B K Hartman
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  A monovalent ion-selective cation current activated by noradrenaline in smooth muscle cells of rabbit ear artery.

Authors:  Q Wang; R C Hogg; W A Large
Journal:  Pflugers Arch       Date:  1993-04       Impact factor: 3.657

Review 3.  Pharmacological aspects of human and canine narcolepsy.

Authors:  S Nishino; E Mignot
Journal:  Prog Neurobiol       Date:  1997-05       Impact factor: 11.685

4.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

5.  Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells.

Authors:  M Steriade; F Amzica; A Nuñez
Journal:  J Neurophysiol       Date:  1993-10       Impact factor: 2.714

6.  Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study.

Authors:  C S Leonard; R Llinás
Journal:  Neuroscience       Date:  1994-03       Impact factor: 3.590

7.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

8.  Immunohistochemical study of choline acetyltransferase-immunoreactive processes and cells innervating the pontomedullary reticular formation in the rat.

Authors:  B E Jones
Journal:  J Comp Neurol       Date:  1990-05-15       Impact factor: 3.215

9.  Dual regulation of cation-selective channels by muscarinic and alpha 1-adrenergic receptors in the rabbit portal vein.

Authors:  R Inoue; H Kuriyama
Journal:  J Physiol       Date:  1993-06       Impact factor: 5.182

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  85 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

2.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

3.  Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.

Authors:  Scott F Davis; Kevin W Williams; Weiye Xu; Nicholas R Glatzer; Bret N Smith
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

4.  Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons.

Authors:  Laurence Bayer; Mauro Serafin; Emmanuel Eggermann; Benoît Saint-Mleux; Danièle Machard; Barbara E Jones; Michel Mühlethaler
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

5.  The lateral paragigantocellular nucleus modulates parasympathetic cardiac neurons: a mechanism for rapid eye movement sleep-dependent changes in heart rate.

Authors:  Olga Dergacheva; Xin Wang; Mary R Lovett-Barr; Heather Jameson; David Mendelowitz
Journal:  J Neurophysiol       Date:  2010-05-19       Impact factor: 2.714

6.  The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.

Authors:  Samir Haj-Dahmane; Roh-Yu Shen
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

7.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

8.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior.

Authors:  Benjamin Boutrel; Paul J Kenny; Sheila E Specio; Rémi Martin-Fardon; Athina Markou; George F Koob; Luis de Lecea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 9.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

10.  Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels.

Authors:  K A Kohlmeier; S Watanabe; C J Tyler; S Burlet; C S Leonard
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.